delirium in the cancer patient - Department of Pain Medicine and ...

More documents

Recommendations

Info

AIDS Delirium StudyDrug Dosages1st 24 hoursHaloperidolChlorpromazineLorazepammean dose 2.6 mgmedian dose 1.75 mgrange .75-6.25 mgmean dose 100 mgmedian dose 70 mgrange 30-257.5 mgmean dose 6.9 mgmedian dose 3.0 mgrange 0.5-20 mg
AIDS Delirium StudyDrug DosagesMaintenance Dose Days 2 - 7Haloperidolmean dose 1.6 mgmedian dose 1.0 mgrange 0.25 – 4.375 mgChlorpromazineLorazepammean dose 40 mgmedian dose 35 mgrange 15 – 175 mgmean dose 1.5 mgmedian dose 1.25 mgrange 1.25 – 2.0 mg
Page 3 and 4: Delirium in Advanced Cancer• Deli
Page 5 and 6: DSM-IV Criteria for Delirium (Con
Page 8: Hypoactive Delirium: Controversies
Page 11 and 12: Delirium Experience Questionnaire
Page 13 and 14: Sample Characteristics (n= 101)•
Page 16 and 17: Percentage of Patients with Deliriu
Page 18 and 19: Distress in Hyperactive vs Hypoacti
Page 20 and 21: Delirium Assessment MethodsDiagnost
Page 22 and 23: Validation of the Memorial Delirium
Page 24 and 25: Assessment of Etiologies of Deliriu
Page 26 and 27: Causes of Delirium in Advanced Canc
Page 28 and 29: Non-Pharmacological Interventions f
Page 30 and 31: Pharmacological Management of Delir
Page 32 and 33: Side Effects of Neuroleptics/Antips
Page 34 and 35: Side Effects of Haloperidol vs.Risp
Page 36 and 37: Clinical Trials of Delirium Managem
Page 44 and 45: Neuroleptics for Hypoactive Deliriu
Page 46 and 47: Efficacy of Olanzapine in the Treat
Page 48 and 49: Logistic Regression Analysis of Pre
Page 50 and 51: Efficacy of Olanzapine in Hypoactiv
Page 52 and 53: Olanzapine Side Effects• Olanzapi
Page 58 and 59: Conclusions• Delirium is a common
Page 60: New JournalPalliative & Supportive

delirium in the cancer patient - Department of Pain Medicine and ...

Create successful ePaper yourself

Delete template?

Save as template?